Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration Resistant Prostate Cancer × TH 302 × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Sarcoma 1 Melanoma 1 Castration Resistant Prostate Cancer 1

Interventions

Triamcinolone Acetonide 1 TH 302 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Injections, Intramuscular 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06836726 2026-01-28

EVO

University Health Network, Toronto

Phase 2 Not yet recruiting

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡